I am looking for reference papers or direct expert feedback about the reliability (Repeatability, Sensitivity, Specificity) of methods for the detection of gene features in the scope of oncology. For instance KRAS mutation detection or HER-2 status. I am also interested in cost analysis related to inter-method variability in patient recruitment for oncologic clinical trials. 

More Hubert Beaumont's questions See All
Similar questions and discussions